AN2 Therapeutics (ANTX) Selling, General & Administrative (2021 - 2026)
AN2 Therapeutics (ANTX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
-7.36 Mn |
| 10 |
AN2 Therapeutics |
161.95 Mn |
161.95 Mn |
- |
3.81 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
3.81 Mn |
| Dec 31, 2025 |
2.44 Mn |
| Sep 30, 2025 |
3.04 Mn |
| Jun 30, 2025 |
4.02 Mn |
| Mar 31, 2025 |
3.85 Mn |
| Dec 31, 2024 |
3.21 Mn |
| Sep 30, 2024 |
3.48 Mn |
| Jun 30, 2024 |
3.73 Mn |
| Mar 31, 2024 |
3.64 Mn |
| Dec 31, 2023 |
3.90 Mn |
| Sep 30, 2023 |
3.75 Mn |
| Jun 30, 2023 |
3.06 Mn |
| Mar 31, 2023 |
4.05 Mn |
| Dec 31, 2022 |
3.72 Mn |
| Sep 30, 2022 |
3.34 Mn |
| Jun 30, 2022 |
3.64 Mn |
| Mar 31, 2022 |
2.05 Mn |
| Dec 31, 2021 |
1.78 Mn |
| Sep 30, 2021 |
1.59 Mn |
| Jun 30, 2021 |
898,000.00 |
